Literature DB >> 17467446

Results of the 1.5-ventricle repair for Ebstein anomaly and the failing right ventricle.

Luis G Quinonez1, Joseph A Dearani, Francisco J Puga, Patrick W O'Leary, David J Driscoll, Heidi M Connolly, Gordon K Danielson.   

Abstract

OBJECTIVE: Repair of Ebstein anomaly and impaired right ventricular function pose challenges for the cardiac surgeon. The bidirectional cavopulmonary shunt may improve early outcomes. We reviewed our experience with the 1.5-ventricle repair in this patient population.
METHODS: Between July 1999 and March 2006, 169 patients underwent operations to repair Ebstein anomaly. Fourteen patients had a bidirectional cavopulmonary shunt constructed. The median age at operation was 6 years (17 months-57.8 years). All of the patients had severe Ebstein anomaly with dilated right-sided chambers and/or right ventricular dysfunction. The mean left ventricular ejection fraction was 54.5% (range 35%-72%). Three patients were initially referred for heart transplantation, and the bidirectional cavopulmonary shunt allowed a conventional repair.
RESULTS: Procedures included bidirectional cavopulmonary shunting (14), tricuspid valve replacement (11), tricuspid valve repair (2), and right ventricular resection (3). Shunting was planned preoperatively in 9 patients; the indication in 5 other patients was hemodynamic instability after separation from cardiopulmonary bypass. One patient died of multiple organ failure. Median follow-up in 10 patients was 18 months (3 months-6.5 years). The preoperative left ventricular ejection fraction of less than 50% improved in 3 patients to greater than 50% postoperatively.
CONCLUSIONS: The 1.5-ventricle repair can be utilized in patients with severe Ebstein anomaly and impaired right ventricular function who are at high risk for surgical treatment. We believe the bidirectional cavopulmonary shunt may be considered as a planned procedure, as an intraoperative salvage maneuver, or as an alternative to cardiac transplantation in selected patients.

Entities:  

Mesh:

Year:  2007        PMID: 17467446     DOI: 10.1016/j.jtcvs.2006.12.007

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  4 in total

1.  Modified Cone Reconstruction of the Tricuspid Valve for Ebstein Anomaly as Performed in Siberia.

Authors:  Evgeny V Krivoshchekov; Jaeger P Ackerman; Olga S Yanulevich; Alexander A Sokolov; Nadezhda V Ershova; Joseph A Dearani; Frank Cetta
Journal:  Tex Heart Inst J       Date:  2017-02-01

2.  Prospective comparison of echocardiography versus cardiac magnetic resonance imaging in patients with Ebstein's anomaly.

Authors:  Christine H Attenhofer Jost; Whitney D Edmister; Paul R Julsrud; Joseph A Dearani; M Savas Tepe; Carole A Warnes; Christopher G Scott; Nandan S Anavekar; Naser M Ammash; Heidi M Connolly
Journal:  Int J Cardiovasc Imaging       Date:  2011-08-06       Impact factor: 2.357

3.  Diagnosis and management of ebstein anomaly of the tricuspid valve.

Authors:  Eric V Krieger; Anne Marie Valente
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-12

4.  Ebstein malformation of the tricuspid valve: current concepts in management and outcomes.

Authors:  Morgan L Brown; Joseph A Dearani
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.